Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil

In 17 patients affected by atherosclerotic vascular disease and showing in basal conditions a hyperviscosity state, we have monitored the main hemorheological determinants during treatment with Suloctidil. At the end of treatment carried out for 5 months the results showed that erythrocyte filterabi...

Full description

Saved in:
Bibliographic Details
Published inRicerca in clinica e in laboratorio Vol. 13 Suppl 3; p. 465
Main Authors Caimi, G, Catania, A, Frazzetta, F, Capobianco, D, Francavilla, G, Romano, A, Sarno, A
Format Journal Article
LanguageItalian
Published Italy 1983
Subjects
Aged
Arterial Occlusive Diseases - blood
Arterial Occlusive Diseases - drug therapy
Blood Viscosity
Erythrocytes - physiology
Female
Fibrinogen - analysis
Hematocrit
Humans
Intracranial Arteriosclerosis - blood
Intracranial Arteriosclerosis - drug therapy
Leg - blood supply
Male
Middle Aged
Propanolamines - therapeutic use
Rheology
Suloctidil - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:In 17 patients affected by atherosclerotic vascular disease and showing in basal conditions a hyperviscosity state, we have monitored the main hemorheological determinants during treatment with Suloctidil. At the end of treatment carried out for 5 months the results showed that erythrocyte filterability was the only hemorheological determinant influenced. The possible causes of this action are therefore considered.
ISSN:0390-5748